CTRI/2018/04/012971已完成4 期
Randomized controlled trial of topical sertaconazole and eberconazole in comparison to topical miconazole in localized dermatophyte infection
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 206
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients suffering from dermatophyte infection in the form of localized tinea lesions such as tinea corporis and tinea cruris.
- •2. Willing to provide written informed consent.
排除标准
- •1. Female patients who are pregnant or breast feeding.
- •2. Patients with disseminated tinea infection.
- •Patients with uncontrolled diabetes mellitus or severely immunocompromising disorders like HIV/AIDS.
- •3. Patients with serious disease of vital organs like heart, lungs, liver, kidney or bone marrow.
- •4. Patients suffering from alcoholism, other substance abuse disorders or active psychiatric disorders.
- •5. Patients with history of hypersensitivity to systemic or topical formulations of azole antifungals including miconazole, sertaconazole or eberconazole.
- •6. Participation in another clinical trial within last 30 days.
- •7. Any other condition, which in the opinion of the principal investigator, will prevent the subject from complying with visit schedules and instructions.
研究者
相似试验
已完成
4 期
A comparison between the efficacy and tolerability of topical sertaconazole and topical terbinafine in localized fungal infections of the skiCTRI/2014/09/005029R G Kar Medical College and Hospital Kolkata194
已完成
3 期
Evaluation of Topical Sertaconazole Efficacy with Cryotherapy versus Cryotherapy with placebo in Treatment of Cutaneous LeishmaniasisCutaneus Leishmaniasis.Cutaneous leishmaniasisIRCT20180623040195N1Shiraz University of Medical Sciences80
已完成
不适用
A randomised controlled trial of the use of topical application of tranexamic acid in primary cemented total hip replacementISRCTN58762744Record Provided by the NHSTCT Register - 2006 Update - Department of Health124
进行中（未招募）
不适用
Randomised Controlled Trial of the Use of Topical Application of Tranexamic Acid in Primary Total Hip Replacement. - (TRANX-H)Blood loss in total hip replacement in patient with ostoearthritis and rheumatoid arthritis.EUCTR2009-012141-34-GBniversity Hospital of North Tees and Hartlepool150
进行中（未招募）
不适用
Randomised Controlled Trial of the Use of Topical Application of Tranexamic Acid in Primary Cemented Total Knee Replacement (TRANX-K). - TRANX-KIn this study Tranexamic acid efficacy in reducing blood loss will be investigated in total knee replacement.Tranexamic acid will be applied topically to the exposed tissue around the knee joint prior to the wound closure and tourniquet release. It is anticipated that this method of administration will be quicker, easier and have less systemic side effect.MedDRA version: 9.1Level: LLTClassification code 10023227Term: Joint replacementEUCTR2007-007813-35-GBniversity Hospital of North Tees and Hartlepool